Understanding Chronic Achilles Tendinopathy: Pathophysiology and Risk Factors

Chronic Achilles tendinopathy represents a persistent, often disabling condition marked by pain, swelling, and functional loss in the Achilles tendon. Unlike acute tendonitis, which involves inflammatory processes following sudden injury, chronic tendinopathy reflects a failed healing response characterized by degenerative changes at the cellular and molecular levels. The tendon becomes thickened, disorganized in its collagen architecture, and prone to micro-tears due to repetitive overload that exceeds the tissue’s intrinsic repair capacity. At the microscopic level, tendinopathic tissue shows increased glycosaminoglycan accumulation, neovascularization, and tenocyte apoptosis, with a shift from type I to type III collagen that reduces tensile strength. This condition commonly affects runners, jumpers, and middle-aged active individuals, and is frequently linked to training errors such as sudden increases in mileage or intensity, inadequate recovery periods, and poor surface transitions. Biomechanical contributors include excessive foot pronation, reduced ankle dorsiflexion range of motion, tight gastrocnemius and soleus muscles, and weak hip stabilizers that alter lower limb loading patterns. Additional risk factors encompass age-related tendon stiffness and decreased vascularity, obesity, diabetes mellitus, dyslipidemia, and prior fluoroquinolone antibiotic use, which can disrupt collagen synthesis. Recognizing these underlying causes is the first critical step toward effective, individualized management.

Assessment and Diagnosis: A Comprehensive Approach

Clinical History and Physical Examination

Accurate diagnosis begins with a detailed history. Patients typically report localized pain 2–6 cm above the calcaneal insertion, morning stiffness lasting 10–30 minutes, and tenderness during weight-bearing activities such as walking uphill, stair climbing, or running. The clinician should palpate the tendon systematically for focal nodules, diffuse thickening, or crepitus, assess active and passive ankle range of motion, and evaluate lower limb alignment and gait. Key diagnostic maneuvers include the “painful arc” sign, where pain shifts with ankle movement from full plantarflexion to dorsiflexion, which helps differentiate tendinopathy from paratenonitis or retrocalcaneal bursitis. The Silfverskiöld test assesses gastrocnemius tightness by comparing ankle dorsiflexion with the knee extended versus flexed. Strength testing of the gastrocnemius-soleus complex using single-leg heel raises quantifies functional deficits and guides rehabilitation progression. Bilateral comparison is essential, as asymptomatic tendons often show subtle differences in thickness and stiffness.

Imaging Studies: When and Why

While clinical diagnosis is often sufficient for straightforward cases, imaging confirms the extent of degeneration and rules out alternative pathology. Ultrasound is widely used due to its low cost, accessibility, and ability to dynamically assess tendon structure, neovascularization, and real-time movement. It can reveal hypoechoic areas, tendon thickening, and partial-thickness tears, with power Doppler detection of neovascularization correlating with pain in some studies. Magnetic resonance imaging (MRI) provides superior soft-tissue contrast and is indicated when surgery is considered, when insertional disorders are suspected, or to exclude bone marrow edema, retrocalcaneal bursitis, or complete rupture. MRI grading systems classify tendinopathy as mild (increased signal without thickening), moderate (focal thickening and signal change), or severe (diffuse thickening with intrasubstance tearing). Neither modality is required for routine care, but both guide treatment decisions in recalcitrant cases. Recent evidence suggests that MRI findings correlate better with symptom severity and functional outcomes than ultrasound, though the choice remains clinician-dependent and should be guided by specific clinical questions.

Conservative Treatment Strategies: The Cornerstone of Management

Activity Modification and Relative Rest

Complete immobilization is rarely beneficial for chronic tendinopathy and can actually worsen outcomes through disuse atrophy and reduced tendon health. Instead, relative rest—reducing high-impact activities while maintaining pain-free load—promotes structural adaptation and healing. Patients should temporarily avoid running, jumping, and explosive movements while substituting with cross-training modalities such as swimming, aqua jogging, cycling, or elliptical training that preserve cardiovascular fitness without stressing the Achilles. Pain during and immediately after activity serves as a useful guide: a Visual Analog Scale (VAS) of 3–4 out of 10 during exercise is acceptable, provided pain returns to baseline within 24 hours. If pain worsens or persists beyond 24 hours, activity volume should be reduced further. The concept of “tendon load monitoring” involves tracking daily step counts, training volume, and pain scores to identify patterns and prevent flare-ups. Patients should be educated that some discomfort during rehabilitation is normal and does not indicate tissue damage, but sharp or worsening pain requires modification.

Eccentric Strengthening: Evidence and Protocols

Eccentric loading remains the gold-standard exercise intervention for mid-portion Achilles tendinopathy, with robust evidence supporting its ability to stimulate collagen cross-linking, tendon remodeling, and improved mechanical properties. The classic Alfredson protocol involves performing 180 heel drops daily, divided into three sets of 15 repetitions with the knee straight (gastrocnemius emphasis) and three sets with the knee bent (soleus emphasis), performed twice per day. The key element is loading the tendon eccentrically while the concentric phase is performed with the uninjured leg or assisted. Patients are instructed to perform these exercises even if they cause mild discomfort (pain up to 5/10 is acceptable), as this reflects mechanical loading rather than injury. However, adherence can be low due to the high volume, time commitment, and discomfort. Recent research has explored lower-volume alternatives such as 6–8 sets of 8 reps performed once daily, with comparable outcomes at 12 weeks. For insertional tendinopathy (pain at the tendon attachment to the calcaneus), a modified protocol with reduced dorsiflexion range is recommended to avoid bony impingement and excessive compression. Eccentric exercises should be continued for at least 12 weeks before assessing response, as structural adaptation typically requires 8–12 weeks.

Heavy Slow Resistance Training: An Emerging Alternative

Heavy slow resistance (HSR) training has gained strong traction as an alternative or adjunct to eccentric exercise. Using free weights, gym machines, or weighted backpacks, patients perform 3–4 sets of 6–15 repetitions of both concentric and eccentric heel raises at 70–90% of their 1-repetition maximum. The movement is executed slowly (3–4 seconds per phase) to maximize tendon strain and stimulate mechanotransduction pathways. A landmark 2015 randomized controlled trial by Beyer et al. found that HSR produced equivalent pain reduction and functional improvements compared to eccentric training, with higher patient satisfaction and adherence. Subsequent meta-analyses have confirmed these findings, showing that both approaches yield 50–70% improvement in pain and function over 12–24 weeks. HSR may be particularly suitable for patients who find high-volume eccentric protocols too painful or time-consuming, or those with lower limb strength deficits that require progressive loading. The protocol can be performed 2–3 times weekly with adequate recovery between sessions, making it more practical for many patients.

Manual Therapy and Stretching

Soft tissue mobilization, including cross-friction massage and myofascial release, targets tension in the calf, hamstring, and plantar fascia, aiming to improve ankle dorsiflexion range of motion and reduce tendon load during gait. A 2019 systematic review reported that combining manual therapy with eccentric exercise yields modestly better short-term outcomes than exercise alone, particularly for pain reduction in the first 4–6 weeks. Static stretching of the gastrocnemius and soleus (30-second holds, 3–4 repetitions per side, performed after exercise) helps maintain flexibility, though isolated stretching without strengthening shows mixed evidence for tendinopathy. Dynamic stretching and foam rolling may be used as part of a warm-up routine to prepare the tendon for loading. Joint mobilization of the talocrural and subtalar joints can also improve ankle biomechanics and reduce compensatory movement patterns.

Pain Management and Patient Education

Effective pain management goes beyond medication. Patients benefit from understanding that chronic tendinopathy is a load-dependent condition, not a purely inflammatory one. Education on tendon biology, the expected timeline of recovery (often 3–6 months for significant improvement), and the importance of adherence to rehabilitation is essential for setting realistic expectations and preventing frustration. Ice can be used for acute flares, but routine icing has limited evidence for chronic tendinopathy. Acetaminophen may be used for pain relief, particularly in patients who cannot tolerate NSAIDs. Topical analgesics such as diclofenac gel or arnica may offer localized relief with minimal systemic side effects.

Adjunctive Treatments: When Conservative Care Isn’t Enough

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

While chronic tendinopathy is not primarily an inflammatory condition, NSAIDs such as ibuprofen or naproxen may provide short-term pain relief during early rehabilitation or acute flares. However, they do not address the underlying degenerative pathology and may potentially impair collagen synthesis with prolonged use. Short courses (5–7 days) are acceptable for managing pain during the initial phase of rehabilitation, but long-term reliance is discouraged due to gastrointestinal, renal, and cardiovascular risks. Topical NSAID formulations such as diclofenac gel offer a lower side-effect profile and can be used for localized pain management over 2–4 weeks.

Extracorporeal Shockwave Therapy (ESWT)

ESWT delivers high-energy acoustic waves to the tendon, stimulating neovascularization, growth factor release, and tissue repair. It is best indicated for mid-portion (non-insertional) tendinopathy that has not responded to at least 3–6 months of conservative therapy. Low-energy ESWT (without local anesthesia) is often preferred over high-energy protocols, as it allows real-time patient feedback for targeting the most painful area and avoids anesthesia-related complications. A meta-analysis of 14 randomized controlled trials found that ESWT significantly reduced pain and improved function compared to placebo at 3–6 months, with effect sizes comparable to eccentric exercise. Success rates range from 60–80% in appropriately selected patients. Contraindications include pregnancy, coagulopathy, local infection, and the presence of malignancy. Typically, 3 sessions are administered at weekly intervals, with the full effect apparent at 8–12 weeks post-treatment.

Platelet-Rich Plasma (PRP) Injections

PRP involves concentrating autologous platelets and injecting them into the degenerated tendon to deliver growth factors, including platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-β), and vascular endothelial growth factor (VEGF), which may stimulate healing. Despite widespread use, evidence remains conflicting. Early small trials showed benefit, but larger, higher-quality randomized controlled trials, such as the PRICE trial (2020), found no significant difference between PRP and saline injections for mid-portion tendinopathy at 6 or 12 months. The 2023 clinical practice guidelines from the American College of Foot and Ankle Surgeons suggest that PRP can be considered for refractory mid-portion tendinopathy, but patients should be counseled on the uncertain efficacy, variable preparation methods, and potential for mild post-injection pain lasting 24–48 hours. Multiple injections spaced 4 weeks apart may be required, and the cost is often not covered by insurance.

Other Orthobiologics and Emerging Therapies

Autologous conditioned serum (Orthokine), bone marrow aspirate concentrate (BMAC), and prolotherapy using hypertonic dextrose have been investigated for chronic tendinopathy, but none yet has robust enough evidence for routine recommendation. Prolotherapy, which involves injecting an irritant solution to stimulate a healing response, has shown some promise in small studies but lacks large-scale randomized data. Low-level laser therapy (LLLT) and therapeutic ultrasound are also used in clinical practice but show weak evidence for chronic Achilles tendinopathy specifically. Corticosteroid injections are not recommended for Achilles tendinopathy, as they provide only temporary relief and significantly increase the risk of tendon rupture due to collagen inhibition and tissue atrophy. Glyceryl trinitrate patches applied topically have shown mixed results, with some studies reporting pain reduction but high rates of headache as a side effect.

A 2017 systematic review in the British Journal of Sports Medicine provides a comprehensive summary of these adjunctive treatments and their evidence levels.

Surgical Options: Indications and Outcomes

When 6–12 months of comprehensive conservative management fails to provide adequate pain relief or functional improvement, surgery may be considered. Surgical success rates in appropriately selected patients range from 70–85%, but recovery is prolonged and outcomes depend heavily on the quality of postoperative rehabilitation.

Open Debridement with Tendon Repair

The most common procedure for mid-portion tendinopathy is open debridement, which involves excising degenerated tissue, excising the paratenon if thickened, and stimulating neovascularization through multiple tenotomies. In cases of partial-thickness tear, the remaining healthy tendon is repaired with nonabsorbable sutures. For patients with substantial tendon tissue loss or attenuation, augmentation using the flexor hallucis longus (FHL) tendon transfer improves plantarflexion strength but may reduce push-off power slightly. Success rates for open debridement are 70–85% at 2–5 years follow-up, with most patients returning to recreational activities. However, recovery is slow, with 4–6 weeks of immobilization in a boot and 6–12 months before full return to sport.

Minimally Invasive Techniques

Endoscopic and percutaneous approaches, including ultrasound-guided tenotomy and needle fenestration (multiple punctures), have gained popularity due to faster recovery times, lower infection rates, and reduced scarring. These techniques target the degenerated area with multiple small-diameter punctures to trigger a healing response through bleeding and growth factor release. A 2018 review of endoscopic soft-tissue release for non-insertional tendinopathy reported a 90% satisfaction rate at 2 years, though long-term data beyond 5 years remain limited. Percutaneous techniques are best suited for patients with discrete tendinopathy nodules rather than diffuse degeneration. Comparative effectiveness studies between open and minimally invasive approaches are limited, but patient selection based on the location and extent of pathology is critical for optimizing outcomes.

Postoperative Rehabilitation

After surgery, patients typically wear a walking boot or cast for 2–4 weeks with the ankle in slight equinus to offload the repair, followed by gradual progression to full weight-bearing in a heel-lift shoe. Formal physical therapy begins at 4–6 weeks with gentle range-of-motion exercises, advancing to isometric strengthening at 6–8 weeks, and eccentric loading at 10–12 weeks. Return to low-impact activity such as swimming can occur around 3–4 months, while high-level jumping, sprinting, or pivoting may require 9–12 months. Adherence to the rehabilitation plan is the single most important factor in achieving good outcomes; noncompliance is a common cause of poor surgical results and recurrence.

The American Academy of Orthopaedic Surgeons (AAOS) OrthoInfo page on Achilles tendinitis provides additional patient-oriented information on surgical and non-surgical approaches.

Prevention and Long-Term Management: Staying Pain-Free

Training Principles and Load Management

Preventing recurrence requires intelligent training habits. Follow the 10% rule for weekly mileage increases, incorporate at least one full rest day per week, and vary training surfaces to avoid constant high-impact loading on hard pavement. Runners should replace shoes every 350–450 miles to maintain adequate cushioning and support. Gradual progression in intensity, duration, and frequency remains the single most important preventive measure. For athletes returning after an Achilles injury, a 2:1 low-impact to high-impact ratio in training volume for the first 4–6 weeks can reduce relapse rates. Monitoring training load using tools such as the acute-to-chronic workload ratio can help identify periods of elevated injury risk.

Strength and Flexibility Maintenance

Sustained calf strength is essential for long-term tendon health. Incorporate 3–4 weekly sessions of eccentric or HSR exercises as maintenance, even after symptoms fully resolve. A simple home program of 3 sets of 15 single-leg heel raises on a step, performed daily on the asymptomatic side and every other day on the symptomatic side, can preserve tendon structural integrity. Daily static and dynamic calf stretches, including downward dog and soleus lunges, help maintain ankle range of motion. Hip and core strengthening exercises, such as clamshells, side planks, and glute bridges, reduce abnormal lower limb loading patterns that contribute to Achilles strain.

Footwear and Orthotics

Proper footwear with adequate heel counter support and a heel-to-toe drop of 10–12 mm reduces Achilles tendon strain during walking and running. For patients with excessive pronation or significant gastrocnemius tightness, over-the-counter heel lifts of 1–2 cm can decrease acute pain during the first 2–3 weeks of rehabilitation, though they should be gradually weaned off to avoid long-term adaptation and shortening of the gastrocnemius-soleus complex. Custom orthotics, while commonly prescribed, show limited additional benefit over generic supports in randomized trials for Achilles tendinopathy, but may be useful for addressing specific biomechanical deficits such as excessive rearfoot eversion.

Lifestyle and Metabolic Factors

Systemic health factors play a significant role in tendon health. Address metabolic syndrome components through weight management, cholesterol control, and glycemic regulation in diabetic patients. Even a 5–10% reduction in body weight can significantly reduce tendon load during daily activities. Adequate protein intake of approximately 1.2–1.6 g per kg of body weight supports collagen synthesis, and vitamin C supplementation of 500–1000 mg daily may aid tissue repair. Avoid smoking and limit alcohol consumption, as both impair collagen metabolism and microvascular function. Emerging evidence suggests that sleep quality and stress management also influence tendon healing through their effects on inflammation and tissue repair pathways.

When to Refer to a Specialist

Primary care providers and physical therapists can manage most cases of chronic Achilles tendinopathy successfully using the conservative strategies outlined above. Referral to a sports medicine physician, orthopaedic foot and ankle surgeon, or a specialist in physical medicine and rehabilitation is indicated when: (1) pain persists beyond 6 months despite compliant, well-structured conservative therapy; (2) imaging confirms a partial-thickness tear involving more than 50% of the tendon cross-section or a complete rupture; (3) there is suspicion of underlying systemic disease such as seronegative spondyloarthropathy, gout, or pseudogout; (4) the patient experiences an acute increase in pain accompanied by plantarflexion weakness, a positive Thompson test, or a palpable tendon gap, suggesting possible rupture; or (5) surgical evaluation is needed after failure of conservative care. Early specialist input can help prevent progression to irreversible structural damage and may reduce the likelihood of surgery by optimizing non-operative management. Multidisciplinary care involving physical therapy, orthopedics, and sports medicine provides the best outcomes for complex or refractory cases.

A 2020 clinical practice guideline published in the Journal of Orthopaedic & Sports Physical Therapy offers a comprehensive evidence-based algorithm for managing Achilles tendinopathy, including clear referral criteria.

By integrating evidence-based conservative care, selecting adjunctive therapies judiciously, and maintaining a comprehensive preventive program, most individuals with chronic Achilles tendinopathy can achieve lasting pain relief and return to their desired activity level. The key principles are consistent load management—neither underloading nor overloading the tendon—and a willingness to adapt treatment over time as symptoms evolve. Patient education, realistic goal-setting, and a structured, progressive rehabilitation plan form the foundation for successful long-term outcomes.

A 2019 meta-analysis in the American Journal of Sports Medicine provides further support for the combination of eccentric training and patient education for optimal outcomes in chronic Achilles tendinopathy.